Efficient systems for delivery of
small interfering RNA (
siRNA) are required for clinical application of RNA interference (RNAi) in
cancer therapy. Herein, we developed a safe and efficient nanocarrier comprising poly(
ethylene glycol)-block-charge-conversional
polymer (PEG-CCP)/
calcium phosphate (CaP) hybrid
micelles for systemic delivery of
siRNA and studied their efficacy in spontaneous bioluminescent pancreatic
tumors from transgenic mice. PEG-CCP was engineered to provide the
siRNA-loaded hybrid
micelles with enhanced colloidal stability and biocompatibility due to the PEG
capsule and with endosome-disrupting functionality due to the acidic pH-responsive CCP segment where the polyanionic structure could be converted to polycationic structure at acidic pH through cis-aconitic
amide cleavage. The resulting hybrid
micelles were confirmed to have a diameter of <50nm, with a narrow size distribution. Intravenously injected hybrid
micelles significantly reduced the
luciferase-based luminescent signal from the spontaneous pancreatic
tumors in an
siRNA sequence-specific manner. The gene silencing activity of the hybrid
micelles correlated with their preferential
tumor accumulation, as indicated by fluorescence imaging and histological analysis. Moreover, there were no significant changes in hematological parameters in mice treated with the hybrid
micelles. These results demonstrate the great potential of the hybrid
micelles as
siRNA carriers for RNAi-based
cancer therapy.